Triggering of death receptor apoptotic signaling by human papillomavirus 16 E2 protein in cervical cancer cell lines is mediated by interaction with c-FLIP

Apoptosis

Volumn 16, Issue 1, 2011, Pages 55-66

  Wang, Wei ^a   Fang, Yong ^a   Sima, Ni ^b   Li, Yan ^a   Li, Wei ^a   Li, Li ^a   Han, Linfei ^a   Liao, Shujie ^a   Han, Zhiqiang ^a   Gao, Qinglei ^a   Li, Kezhen ^a   Deng, Dongrui ^a   Meng, Li ^a   Zhou, Jianfeng ^a   Wang, Shixuan ^a   Ma, Ding ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Zhejiang University School of Medicine   (China)

Author keywords

Apoptosis; Cervical carcinogenesis; cFLIP; Death receptor signaling; HPV E2

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 8 INHIBITOR; DEATH RECEPTOR; FAS ANTIBODY; FLICE INHIBITORY PROTEIN; GLYCOPROTEIN E2; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIUM CELL; GENE DISRUPTION; GENE OVEREXPRESSION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNOPRECIPITATION; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UTERINE CERVIX CANCER; UTERINE CERVIX EPITHELIUM;

ANTIBODIES, MONOCLONAL; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 3; CASPASE 8; CELL LINE, TUMOR; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; RECEPTORS, DEATH DOMAIN; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 79951552273     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-010-0543-3     Document Type: Article

References (33)

1. FX Bosch A Lorincz N Munoz CJ Meijer KV Shah 2002 The causal relation between human papillomavirus and cervical cancer J Clin Pathol 55 244 265 1:STN:280:DC%2BD383jtlOisg%3D%3D 11919208 (Pubitemid 34293391)
2. N Munoz FX Bosch S de Sanjose, et al. 2003 Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 348 518 527 10.1056/NEJMoa021641 12571259 (Pubitemid 36159887)
3. K Münger PM Howley 2002 Human papillomavirus immortalization and transformation functions Virus Res 89 213 228 10.1016/S0168-1702(02)00190-9 12445661 (Pubitemid 35351540)
4. AA Antson JE Burns OV Moroz DJ Scott CM Sanders IB Bronstein GG Dodson KS Wilson NJ Maitland 2000 Structure of the intact transactivation domain of the human papillomavirus E2 protein Nature 403 805 809 1:CAS:528: DC%2BD3cXhsVWiu7c%3D 10.1038/35001638 10693813 (Pubitemid 30111845)
5. S Blachon C Demeret 2003 The regulatory E2 proteins of human genital papillomaviruses are pro-apoptotic Biochimie 85 813 819 1:CAS:528: DC%2BD3sXosVymsbg%3D 10.1016/j.biochi.2003.09.008 14585548 (Pubitemid 37383800)
6. S Vinokurova N Wentzensen I Kraus R Klaes C Driesch, et al. 2008 Type-dependent integration frequency of human papillomavirus genomes in cervical lesions Cancer Res 68 307 313 1:CAS:528:DC%2BD1cXoslWk 10.1158/0008-5472.CAN- 07-2754 18172324 (Pubitemid 351380133)
7. DA Graham CS Herrington 2000 HPV-16 E2 gene disruption and sequence variation in CIN 3 lesions and invasive squamous cell carcinomas of the cervix: relation to numerical chromosome abnormalities Mol Pathol 53 201 206 1:CAS:528:DC%2BD3cXmsVOhtLk%3D 10.1136/mp.53.4.201 11040943 (Pubitemid 30603075)
8. A Nishimura T Ono A Ishimoto JJ Dowhanick MA Frizzell PM Howley H Sakai 2000 Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition J Virol 74 8 3752 3760 1:CAS:528:DC%2BD3cXitFOltr0%3D 10.1128/JVI.74.8.3752-3760.2000 10729150 (Pubitemid 30180318)
9. C Desaintes S Goyat S Garbay M Yaniv F Thierry 1999 Papillomavirus E2 induces p53-independent apoptosis in HeLa cells Oncogene 18 4538 4545 1:CAS:528:DyaK1MXlslCrtbk%3D 10.1038/sj.onc.1202818 10467398 (Pubitemid 29405885)
10. K Webster J Parish M Pandya PL Stern AR Clarke K Gaston 2000 The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway J Biol Chem 275 87 94 1:CAS:528:DC%2BD3cXjvVGlug%3D%3D 10.1074/jbc.275.1.87 10617590 (Pubitemid 30038957)
11. C Demeret A Garcia-Carranca F Thierry 2003 Transcription independent triggering of the extrinsic pathway of apoptosis by human papillomavirus 18 E2 protein Oncogene 22 168 175 1:CAS:528:DC%2BD3sXjtlGjtQ%3D%3D 10.1038/sj.onc.1206108 12527886 (Pubitemid 36174174)
12. Y Shoji M Saegusa Y Takano M Ohbu I Okayasu 1996 Correlation of apoptosis with tumour cell differentiation, progression, and HPV infection in cervical carcinoma J Clin Pathol 49 134 138 1:STN:280:DyaK283msVCgsQ%3D%3D 10.1136/jcp.49.2.134 8655679 (Pubitemid 26064919)
13. A Aguilar-Lemarroy S Kirchhoff N Whitaker P Gariglio H zur Hausen PH Krammer F Rösl 2001 Differential sensitivity of human papillomavirus type 16(+) and type 18(+) cervical carcinoma cells to CD95-mediated apoptosis Int J Cancer 93 823 831 1:CAS:528:DC%2BD3MXlvF2mtbc%3D 10.1002/ijc.1405 11519044 (Pubitemid 32756752)
14. A Krueger S Baumann PH Krammer S Kirchhoff 2001 FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis Mol Cell Biol 21 8247 8254 1:CAS:528:DC%2BD3MXovVegs7o%3D 10.1128/MCB.21.24.8247-8254.2001 11713262 (Pubitemid 33108586)
15. M Djerbi V Screpanti AI Catrina, et al. 1999 The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors J Exp Med 190 1025 1032 1:CAS:528:DyaK1MXmsVClt7Y%3D 10.1084/jem.190.7.1025 10510092 (Pubitemid 29480831)
16. W Wang S Wang X Song N Sima X Xu, et al. 2007 The relationship between c-FLIP expression and human papillomavirus E2 gene disruption in cervical carcinogenesis Gynecol Oncol 105 571 577 1:CAS:528:DC%2BD2sXlsFKisb0%3D 10.1016/j.ygyno.2007.01.051 17433827 (Pubitemid 46734183)
17. A Dutton LS Young PG Murray 2006 The role of cellular FLICE inhibitory protein (c-FLIP) in the pathogenesis and treatment of cancer Expert Opin Ther Targets 10 27 35 1:CAS:528:DC%2BD28XotlGhsQ%3D%3D 10.1517/14728222.10.1.27 16441226 (Pubitemid 43263265)
18. IH Frazer 2004 Prevention of cervical cancer through papillomavirus vaccination Nat Rev Immunol 4 46 54 1:CAS:528:DC%2BD2cXkvVCiug%3D%3D 10.1038/nri1260 14704767 (Pubitemid 38084131)
19. N Zou BY Lin F Duan KY Lee G Jin, et al. 2000 The hinge of the human papillomavirus type 11 E2 protein contains major determinants for nuclear localization and nuclear matrix association J Virol 74 3761 3770 1:CAS:528:DC%2BD3cXitFOltro%3D 10.1128/JVI.74.8.3761-3770.2000 10729151 (Pubitemid 30180319)
20. KH Kim BL Seong 2003 Pro-apoptotic function of HBV X protein is mediated by interaction with c-FLIP and enhancement of death-inducing signal EMBO J 22 2104 2116 1:CAS:528:DC%2BD3sXjsVKmu7g%3D 10.1093/emboj/cdg210 12727877 (Pubitemid 36565535)
21. KH Lee C Feig V Tchikov R Schickel C Hallas, et al. 2006 The role of receptor internalization in CD95 signaling EMBO J 25 1009 1023 1:CAS:528:DC%2BD28XitVyis70%3D 10.1038/sj.emboj.7601016 16498403 (Pubitemid 43372115)
22. JP Medema C Scaffidi FC Kischkel A Shevchenko M Mann PH Krammer ME Peter 1997 FLICE is activated by association with the CD95 death-inducing signaling complex (DISC) EMBO J 16 2794 2804 1:CAS:528:DyaK2sXjsF2mtL0%3D 10.1093/emboj/16.10.2794 9184224 (Pubitemid 27226216)
23. MR Schweiger M Ottinger J You PM Howley 2007 Brd4-independent transcriptional repression function of the papillomavirus e2 proteins J Virol 81 9612 9622 1:CAS:528:DC%2BD2sXhtVeht7jP 10.1128/JVI.00447-07 17626100 (Pubitemid 350067667)
24. F Thierry MA Benotmane C Demeret M Mori S Teissier C Desaintes 2004 A genomic approach reveals a novel mitotic pathway in papillomavirus carcinogenesis Cancer Res 64 895 903 1:CAS:528:DC%2BD2cXhtFCgtbo%3D 10.1158/0008-5472.CAN-03-2349 14871818 (Pubitemid 38176890)
25. RM Ordóñez AM Espinosa DJ Sánchez-González J Armendáriz-Borunda J Berumen 2004 Enhanced oncogenicity of Asian-American human papillomavirus 16 is associated with impaired E2 repression of E6/E7 oncogene transcription J Gen Virol 85 1433 1444 10.1099/vir.0.19317-0 15166426 (Pubitemid 38811424)
26. H Romanczuk PM Howley 1992 Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity Proc Natl Acad Sci USA 89 3159 3163 1:CAS:528:DyaK38XitFaju70%3D 10.1073/pnas.89.7.3159 1313584
27. DA Francis SI Schmid PM Howley 2000 Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells J Virol 74 2679 2686 1:CAS:528:DC%2BD3cXhsFCiurs%3D 10.1128/JVI.74.6.2679-2686.2000 10684283 (Pubitemid 30117578)
28. KA Raclaw HV Heemers EM Kidd SM Dehm DJ Tindall 2008 Induction of FLIP expression by androgens protects prostate cancer cells from TRAIL-mediated apoptosis Prostate 68 1696 1706 1:CAS:528:DC%2BD1cXhsVeqs7fJ 10.1002/pros.20844 18726983
29. GJ Ullenhag A Mukherjee NF Watson AH Al-Attar JH Scholefield LG Durrant 2007 Overexpression of FLIPL is an independent marker of poor prognosis in colorectal cancer patients Clin Cancer Res 13 5070 5075 1:CAS:528: DC%2BD2sXpvFGru7Y%3D 10.1158/1078-0432.CCR-06-2547 17785559 (Pubitemid 47502072)
30. C Scaffidi I Schmitz PH Krammer ME Peter 1999 The role of c-FLIP in modulation of CD95-induced apoptosis J Biol Chem 274 1541 1548 1:CAS:528:DyaK1MXpsFOhsQ%3D%3D 10.1074/jbc.274.3.1541 9880531 (Pubitemid 29057975)
31. LE French J Tschopp 2002 Defective death receptor signaling as a cause of tumor immune escape Semin Cancer Biol 12 51 55 1:CAS:528:DC%2BD38XhvFCkurk%3D 10.1006/scbi.2001.0405 11926412 (Pubitemid 34087898)
32. H Kase Y Aoki K Tanaka 2003 Fas ligand expression in cervical adenocarcinoma: relevance to lymph node metastasis and tumor progression Gynecol Oncol 90 70 74 1:CAS:528:DC%2BD3sXkvVaqs7Y%3D 10.1016/S0090-8258(03)00206-3 12821344 (Pubitemid 37338078)
33. R Konno T Takano S Sato, et al. 2000 Serum soluble fas level as a prognostic factor in patients with gynecological malignancies Clin Cancer Res 6 3576 3580 1:CAS:528:DC%2BD3cXntFCisLg%3D 10999747